These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 28915854)
1. Medical therapy following hospitalization for heart failure with reduced ejection fraction and association with discharge to long-term care: a cross-sectional analysis of the REasons for Geographic And Racial Differences in Stroke (REGARDS) population. Levitan EB; Van Dyke MK; Chen L; Durant RW; Brown TM; Rhodes JD; Olubowale O; Adegbala OM; Kilgore ML; Blackburn J; Albright KC; Safford MM BMC Cardiovasc Disord; 2017 Sep; 17(1):249. PubMed ID: 28915854 [TBL] [Abstract][Full Text] [Related]
2. Pharmacotherapy Treatment Patterns, Outcomes, and Health Resource Utilization Among Patients with Heart Failure with Reduced Ejection Fraction at a U.S. Academic Medical Center. Bress AP; King JB; Brixner D; Kielhorn A; Patel HK; Maya J; Lee VC; Biskupiak J; Munger M Pharmacotherapy; 2016 Feb; 36(2):174-86. PubMed ID: 26841333 [TBL] [Abstract][Full Text] [Related]
3. Clinical Course of Patients With Worsening Heart Failure With Reduced Ejection Fraction. Butler J; Yang M; Manzi MA; Hess GP; Patel MJ; Rhodes T; Givertz MM J Am Coll Cardiol; 2019 Mar; 73(8):935-944. PubMed ID: 30819362 [TBL] [Abstract][Full Text] [Related]
4. Feature and impact of guideline-directed medication prescriptions for heart failure with reduced ejection fraction accompanied by chronic kidney disease. Chen YL; Hang CL; Su CH; Wu PJ; Chen HC; Fang HY; Fang YN; Cheng CI; Fu M; Chen SM Int J Med Sci; 2021; 18(12):2570-2580. PubMed ID: 34104088 [No Abstract] [Full Text] [Related]
5. Variation in use and dosing escalation of renin angiotensin system, mineralocorticoid receptor antagonist, angiotensin receptor neprilysin inhibitor and beta-blocker therapies in heart failure and reduced ejection fraction: Association of comorbidities. Albert NM; Tyson RJ; Hill CL; DeVore AD; Spertus JA; Duffy C; Butler J; Patterson JH; Hernandez AF; Williams FB; Thomas L; Fonarow GC Am Heart J; 2021 May; 235():82-96. PubMed ID: 33497697 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of Chronic Obstructive Pulmonary Disease (COPD) and reduced ejection fraction heart failure (HFrEF) discharge medication prescribing: Is drug therapy concordant with national guidelines associated with a reduction in 30-day readmissions? Richardson A; Tolley E; Hartmann J; Reedus J; Bowlin B; Finch C; Sands CW; Self T Respir Med; 2016 Oct; 119():135-140. PubMed ID: 27692135 [TBL] [Abstract][Full Text] [Related]
8. Physicians' guideline adherence is associated with better prognosis in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry. Komajda M; Cowie MR; Tavazzi L; Ponikowski P; Anker SD; Filippatos GS; Eur J Heart Fail; 2017 Nov; 19(11):1414-1423. PubMed ID: 28463464 [TBL] [Abstract][Full Text] [Related]
9. Medical therapy of heart failure with reduced ejection fraction: current evidence and new developments. Naegele M; Flammer AJ; Enseleit F; Ruschitzka F Swiss Med Wkly; 2016; 146():w14295. PubMed ID: 26968014 [TBL] [Abstract][Full Text] [Related]
10. Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials. Vaduganathan M; Claggett BL; Jhund PS; Cunningham JW; Pedro Ferreira J; Zannad F; Packer M; Fonarow GC; McMurray JJV; Solomon SD Lancet; 2020 Jul; 396(10244):121-128. PubMed ID: 32446323 [TBL] [Abstract][Full Text] [Related]
11. Estimated 5-Year Number Needed to Treat to Prevent Cardiovascular Death or Heart Failure Hospitalization With Angiotensin Receptor-Neprilysin Inhibition vs Standard Therapy for Patients With Heart Failure With Reduced Ejection Fraction: An Analysis of Data From the PARADIGM-HF Trial. Srivastava PK; Claggett BL; Solomon SD; McMurray JJV; Packer M; Zile MR; Desai AS; Rouleau JL; Swedberg K; Fonarow GC JAMA Cardiol; 2018 Dec; 3(12):1226-1231. PubMed ID: 30484837 [TBL] [Abstract][Full Text] [Related]
12. Relationship Between Medical Therapy, Long-Term Care Insurance, and Comorbidity in Elderly Patients With Heart Failure With Systolic Dysfunction. Kase M; Fujiki S; Kashimura T; Okura Y; Kodera K; Watanabe H; Takahashi K; Bannai S; Hatano T; Tanaka T; Kitamura N; Minamino T; Inomata T Circ J; 2023 Jul; 87(8):1130-1137. PubMed ID: 36928271 [TBL] [Abstract][Full Text] [Related]
13. Optimization of heart FailUre medical Treatment after hospital discharge according to left ventricUlaR Ejection fraction: the FUTURE survey. Cohen Solal A; Leurs I; Assyag P; Beauvais F; Clerson P; Contre C; Thebaut JF; Genoun M; Arch Cardiovasc Dis; 2012; 105(6-7):355-65. PubMed ID: 22800720 [TBL] [Abstract][Full Text] [Related]
14. Initiation, Continuation, or Withdrawal of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers and Outcomes in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction. Gilstrap LG; Fonarow GC; Desai AS; Liang L; Matsouaka R; DeVore AD; Smith EE; Heidenreich P; Hernandez AF; Yancy CW; Bhatt DL J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28189999 [TBL] [Abstract][Full Text] [Related]
15. Contemporary Drug Treatment of Chronic Heart Failure With Reduced Ejection Fraction: The CHECK-HF Registry. Brunner-La Rocca HP; Linssen GC; Smeele FJ; van Drimmelen AA; Schaafsma HJ; Westendorp PH; Rademaker PC; van de Kamp HJ; Hoes AW; Brugts JJ; JACC Heart Fail; 2019 Jan; 7(1):13-21. PubMed ID: 30606482 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of Quality of Care for US Veterans With Recent-Onset Heart Failure With Reduced Ejection Fraction. Sandhu AT; Kohsaka S; Turakhia MP; Lewis EF; Heidenreich PA JAMA Cardiol; 2022 Feb; 7(2):130-139. PubMed ID: 34757380 [TBL] [Abstract][Full Text] [Related]
17. Medical Therapy During Hospitalization for Heart Failure With Reduced Ejection Fraction: The VICTORIA Registry. Greene SJ; Ezekowitz JA; Anstrom KJ; Demyanenko V; Givertz MM; Piña IL; O'Connor CM; Koglin J; Roessig L; Hernandez AF; Armstrong PW; Mentz RJ J Card Fail; 2022 Jul; 28(7):1063-1077. PubMed ID: 35301107 [TBL] [Abstract][Full Text] [Related]
18. Effects of ACE inhibitors or beta-blockers in patients treated with the fixed-dose combination of isosorbide dinitrate/hydralazine in the African-American Heart Failure Trial. Ghali JK; Tam SW; Ferdinand KC; Lindenfeld J; Sabolinski ML; Taylor AL; Worcel M; Curry CL; Cohn JN; Am J Cardiovasc Drugs; 2007; 7(5):373-80. PubMed ID: 18041162 [TBL] [Abstract][Full Text] [Related]
19. Treatment Initiation Patterns, Modifications, and Medication Adherence Among Newly Diagnosed Heart Failure Patients: A Retrospective Claims Database Analysis. Deschaseaux C; McSharry M; Hudson E; Agrawal R; Turner SJ J Manag Care Spec Pharm; 2016 May; 22(5):561-71. PubMed ID: 27123917 [TBL] [Abstract][Full Text] [Related]
20. Eligibility and Projected Benefits of Rapid Initiation of Quadruple Therapy for Newly Diagnosed Heart Failure. Greene SJ; Ayodele I; Pierce JB; Khan MS; Lewsey SC; Yancy CW; Alhanti B; Van Spall HGC; Allen LA; Fonarow GC JACC Heart Fail; 2024 Aug; 12(8):1365-1377. PubMed ID: 38597866 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]